GlassScriptPhysician profile
David J Hobbs
NPI 1174886279
$534.19
in general payments reported to CMS, 2019-2025
13 companies · $37.94 in 2025
The $37.94 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $224 · 2022: $115 · 2023: $38.53 · 2025: $37.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $196.56 | 2020 | |
| Ethicon US, LLC | $67.54 | 2019-2025 | Stratafix |
| Braintree Laboratories, INC. | $44.44 | 2020-2022 | |
| Integra Lifesciences Corporation | $41.75 | 2022 | |
| Davol INC. | $31.87 | 2019 | |
| Tela Bio, INC. | $24.62 | 2022 | |
| Exact Sciences Corporation | $22.92 | 2023 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $20.31 | 2019 | |
| W. L. Gore & Associates, INC. | $19.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.65 | 2025 | |
| Olympus America INC. | $18.25 | 2019 | |
| Organogenesis INC. | $15.61 | 2023 | Puraply |
| Pacira Pharmaceuticals Incorporated | $11.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.